Analgesic effect of thalidomide on inflammatory pain

被引:84
作者
Ribeiro, RA
Vale, ML
Ferreira, SH
Cunha, FQ
机构
[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil
基金
巴西圣保罗研究基金会;
关键词
thalidomide; TNF-alpha (tumor necrosis factor-alpha); hyperalgesia; inflammatory; pain;
D O I
10.1016/S0014-2999(99)00918-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tumor necrosis factor alpha (TNF-alpha) may have a pivotal role in the genesis of mechanical inflammatory hyperalgesia in rats and in the nociceptive writhing response in mice. Thalidomide has been shown to selectively inhibit TNF-alpha production. We therefore investigated the effect of thalidomide on these responses as well as on the hot plate response in mice. Hyperalgesic responses to intraplantar (i.pl.) injections of carrageenin or bradykinin, which act by stimulating TNF-alpha release, but not responses to TNF-alpha or prostaglandin E-2, were inhibited in a dose-dependent manner by pretreatment of the animals with thalidomide. The nociceptive writhing responses induced by intraperitoneal (i.p.) injections of zymosan or acetic acid were also inhibited in a dose-dependent manner by pretreatment of mice with thalidomide. Moreover, the thalidomide pretreatment also reduced the TNF-alpha mRNA levels in the peritoneal cells induced by injection of zymosan in mice. The analgesic effect of thalidomide is not due to a central effect, since the drug had no effect in the hot plate test. The demonstration that thalidomide is able to inhibit inflammatory hyperalgesia in rats and the writhing nociceptive response in mice suggests that these analgesic effects seem to be a consequence of the inhibition of TNF-alpha production. and indicates the need for investigations on the possibility of the use of thalidomide for the treatment of pain refractory to classical non-narcotic analgesics. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 34 条
[1]  
AARESTRUP FM, 1995, BRAZ J MED BIOL RES, V28, P1069
[2]   ABDOMINAL CONSTRICTION RESPONSE AND ITS SUPPRESSION BY ANALGESIC DRUGS IN MOUSE [J].
COLLIER, HOJ ;
DINNEEN, LC ;
JOHNSON, CA ;
SCHNEIDER, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1968, 32 (02) :295-+
[3]  
CROSARAALBERTO DP, 1997, P 4 INT C IMM CONS T, P333
[4]   THE PIVOTAL ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA IN THE DEVELOPMENT OF INFLAMMATORY HYPERALGESIA [J].
CUNHA, FQ ;
POOLE, S ;
LORENZETTI, BB ;
FERREIRA, SH .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) :660-664
[5]   Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4 [J].
Cunha, FQ ;
Poole, S ;
Lorenzetti, BB ;
Veiga, FH ;
Ferreira, SH .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (01) :45-50
[6]   INTERLEUKIN-8 AS A MEDIATOR OF SYMPATHETIC PAIN [J].
CUNHA, FQ ;
LORENZETTI, BB ;
POOLE, S ;
FERREIRA, SH .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (03) :765-767
[7]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[8]   TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1 [J].
DINARELLO, CA ;
CANNON, JG ;
WOLFF, SM ;
BERNHEIM, HA ;
BEUTLER, B ;
CERAMI, A ;
FIGARI, IS ;
PALLADINO, MA ;
OCONNOR, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1433-1450
[9]  
Dubost JJ, 1997, REV RHUM, V64, P789
[10]  
EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385